This week in industry news, the Natural Products Association (NPA) won a significant court ruling against the FDA, halting its retroactive enforcement against nicotinamide mononucleotide (NMN) supplements, a move praised by NPA president Daniel Fabricant as a victory for industry and consumer rights. Meanwhile, PanTheryx launched Relesium, a supplement aimed at mitigating gut issues associated with popular GLP-1 medications. Newcomer Cachorrisimo entered the pet food market with a line inspired by Hispanic culinary traditions, appealing to culturally conscious pet owners.
